First PREMIER Bank - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 38 filers reported holding SAB BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
First PREMIER Bank ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$509
-24.0%
807,5350.0%0.16%
-18.3%
Q2 2023$670
+88.7%
807,5350.0%0.19%
+85.4%
Q1 2023$355
-25.4%
807,5350.0%0.10%
-28.5%
Q4 2022$476
-99.9%
807,5350.0%0.14%
-22.2%
Q3 2022$566,000
-40.2%
807,535
+23.8%
0.18%
-34.4%
Q2 2022$946,000
-85.5%
652,440
-21.6%
0.28%
-83.2%
Q4 2021$6,502,000832,5551.68%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
First PREMIER Bank 652,440$946,0000.28%
METEORA CAPITAL, LLC 292,538$424,0000.08%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 78,115$113,0000.02%
SILVER OAK SECURITIES, Inc 51,941$64,0000.01%
Shaolin Capital Management LLC 275,000$399,0000.01%
Elgethun Capital Management 13,296$18,0000.01%
LGL PARTNERS, LLC 23,000$33,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,000$122,0000.00%
Spectrum Management Group, LLC 5,030$7,0000.00%
Veritable, L.P. 43,551$63,0000.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders